- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fredun Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter and half-year. The company is a diversified pharma player with a strong presence in generics, nutraceuticals, pet care, cosmeceuticals, and mobility segments. It operates globally across 52 countries with a portfolio of 697 registered products and over 1,200 under registration. Recent expansions include launching a dedicated pet diagnostic center, entering large animal healthcare, and retail outlets at railway platforms. Capacity enhancements at its Palghar facility aim to boost production. Strong revenue growth continues, supported by increasing product launches and contract wins in institutional and government sectors.